[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Familial Mediterranean Fever Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 49 pages | ID: FF091EC6173EN
VPAResearch

US$ 630.00 US$ 700.00 -10 %
Offer valid until December 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Familial Mediterranean Fever ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Familial Mediterranean Fever disease clinical trials. The research work analyzes the ongoing Familial Mediterranean Fever clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Familial Mediterranean Fever treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Familial Mediterranean Fever clinical trials.

Scope of the Report-
  • Ongoing Familial Mediterranean Fever clinical trials across regions
  • Trial information by Phase and Subjects recruited
  • Trial information by status, type, sponsor type
  • Drugs used for treatment of Familial Mediterranean Fever
  • Both observational and interventional trials analyzed
  • Leading companies and universities participating in Familial Mediterranean Fever clinical trials
Reasons to Buy
  • Track competition and design competitive advantages
  • Identify right partners to associate with for further research
  • Evaluate potential opportunities available in further clinical trials of the disease
  • Formulate business development strategies through success rates of clinical trials
  • Identify quick markets for recruiting subjects based on trials count by each market
1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Familial Mediterranean Fever Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Familial Mediterranean Fever Trials by Phase
3.2 Ongoing Familial Mediterranean Fever Trials by Type
3.3 Ongoing Familial Mediterranean Fever Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Familial Mediterranean Fever Trials
4.2 Top 10 Countries conducting Familial Mediterranean Fever Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Familial Mediterranean Fever Trials by Sponsor Type
5.2 Familial Mediterranean Fever Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Familial Mediterranean Fever Trials by year
6.2 Subjects Recruited for Familial Mediterranean Fever Trials by Phase
6.3 Subjects Recruited for Familial Mediterranean Fever Trials by Trial Type
6.4 Subjects Recruited for Familial Mediterranean Fever Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Familial Mediterranean Fever Trials- Phase
7.2 Ongoing Familial Mediterranean Fever Trials- Phase
7.3 Ongoing Familial Mediterranean Fever Trials- Phase
7.4 Ongoing Familial Mediterranean Fever Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

LIST OF FIGURES

Figure 1: Familial Mediterranean Fever- Clinical Trials by Country
Figure 2: Familial Mediterranean Fever- Clinical Trials by Phase of Development, 2018
Figure 3: Familial Mediterranean Fever- Clinical Trials by Status, 2018
Figure 4: Familial Mediterranean Fever- Clinical Trials by Type, 2018
Figure 5: Familial Mediterranean Fever- Clinical Trials Split by Region, 2000-2018
Figure 6: Familial Mediterranean Fever- Clinical Trials by Type of Economy, 2018
Figure 7: Familial Mediterranean Fever- Enrolment by Phase, 2018
Figure 8: Familial Mediterranean Fever- Enrolment by Trial Type, 2018
Figure 9: Familial Mediterranean Fever- Enrolment by Recruitment Status, 2018
Figure 10: Familial Mediterranean Fever- Clinical Trials by Sponsor Type, 2018
Figure 11: Familial Mediterranean Fever- Enrolment by Type of Sponsors
Figure 12: Familial Mediterranean Fever- Enrolment by Leading Sponsors

LIST OF TABLES

Table 1: Familial Mediterranean Fever- Clinical Trials by Sponsor Type, 2018
Table 2: Familial Mediterranean Fever- Clinical Trials by Economy Type, 2018
Table 3: Familial Mediterranean Fever- Clinical Trials by Region, 2018
Table 4: Familial Mediterranean Fever- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Familial Mediterranean Fever- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Familial Mediterranean Fever- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Familial Mediterranean Fever- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Familial Mediterranean Fever- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Familial Mediterranean Fever- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company


More Publications